Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides

por Ghosh, Nilanjan, Katare, Rajesh
Publicado 2018

Novel immunobiologics for psoriasis

por Ghosh, Nilanjan, Singh, P.N., Kumar, Vikas
Publicado 2008

Topological arrangement of the intracellular membrane fusion machinery

por Rathore, Shailendra S., Ghosh, Nilanjan, Ouyang, Yan, Shen, Jingshi
Publicado 2011

Expanding role of lenalidomide in hematologic malignancies

por Ghosh, Nilanjan, Grunwald, Michael R, Fasan, Omotayo, Bhutani, Manisha
Publicado 2015

In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design

por Sar, Shuvam, Mitra, Soumya, Panda, Parthasarathi, Mandal, Subhash C., Ghosh, Nilanjan, Halder, Amit Kumar, Cordeiro, Maria Natalia D. S.
Publicado 2023

PD-L1 Status in Refractory Lymphomas

por Vranic, Semir, Ghosh, Nilanjan, Kimbrough, Jeffery, Bilalovic, Nurija, Bender, Ryan, Arguello, David, Veloso, Yvonne, Dizdarevic, Aida, Gatalica, Zoran
Publicado 2016

Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies

por Ghosh, Nilanjan, Chacko, Leena, Bhattacharya, Hiranmoy, Vallamkondu, Jayalakshmi, Nag, Sagnik, Dey, Abhijit, Karmakar, Tanushree, Reddy, P. Hemachandra, Kandimalla, Ramesh, Dewanjee, Saikat
Publicado 2023

Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks

por Ghosh, Nilanjan, Chacko, Leena, Vallamkondu, Jayalakshmi, Banerjee, Tanmoy, Sarkar, Chandrima, Singh, Birbal, Kalra, Rajkumar Singh, Bhatti, Jasvinder Singh, Kandimalla, Ramesh, Dewanjee, Saikat
Publicado 2023

Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry

por Mato, Anthony R., Ghosh, Nilanjan, Sharman, Jeff P., Brander, Danielle, Gutierrez, Meghan, Huang, Qing, Wu, Linda H., Young, Alex, Upasani, Sandhya, Naganuma, Maoko, Barrientos, Jacqueline C.
Publicado 2022

Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial

por Morschhauser, Franck, Ghosh, Nilanjan, Lossos, Izidore S., Palomba, M. Lia, Mehta, Amitkumar, Casasnovas, Olivier, Stevens, Don, Katakam, Sudhakar, Knapp, Andrea, Nielsen, Tina, McCord, Ron, Salles, Gilles
Publicado 2021

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

por Wang, Michael, Schuster, Stephen J., Phillips, Tycel, Lossos, Izidore S., Goy, Andre, Rule, Simon, Hamadani, Mehdi, Ghosh, Nilanjan, Reeder, Craig B., Barnett, Evelyn, Bravo, Marie-Laure Casadebaig, Martin, Peter
Publicado 2017

Therapeutic knockdown of miR-320 improves deteriorated cardiac function in a pre-clinical model of non-ischemic diabetic heart disease

por Ghosh, Nilanjan, Fenton, Sonya, van Hout, Isabelle, Jones, Gregory T., Coffey, Sean, Williams, Michael J.A., Sugunesegran, Ramanen, Parry, Dominic, Davis, Philip, Schwenke, Daryl O., Chatterjee, Anirudha, Katare, Rajesh
Publicado 2022

COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients

por Shahid, Zainab, Patrick, Alicia L., Wallander, Michelle L., Donahue, Erin E., Trufan, Sally J., Tan, Antoinette R., Hwang, Jimmy J., Burgess, Earle F., Ragon, Brittany, Ghosh, Nilanjan, Grunwald, Michael R., Voorhees, Peter M., Copelan, Edward A., Raghavan, Derek
Publicado 2023

Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry

por Mato, Anthony R., Barrientos, Jacqueline C., Ghosh, Nilanjan, Pagel, John M., Brander, Danielle M., Gutierrez, Meghan, Kadish, Karen, Tomlinson, Brian, Iyengar, Reethi, Ipe, David, Upasani, Sandhya, Amaya-Chanaga, Carlos I., Sundaram, Murali, Han, Jennifer, Giafis, Nick, Sharman, Jeff P.
Publicado 2019

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

por Dickinson, Michael, Briones, Javier, Herrera, Alex F., González-Barca, Eva, Ghosh, Nilanjan, Cordoba, Raul, Rutherford, Sarah C., Bournazou, Eirini, Labriola-Tompkins, Emily, Franjkovic, Izolda, Chesne, Evelyne, Brouwer-Visser, Jurriaan, Lechner, Katharina, Brennan, Barbara, Nüesch, Eveline, DeMario, Mark, Rüttinger, Dominik, Kornacker, Martin, Hutchings, Martin
Publicado 2021

The iR(2) regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: A multicentre, non-randomised, open-label phase 2 study

por Ramchandren, Radhakrishnan, Johnson, Peter, Ghosh, Nilanjan, Ruan, Jia, Ardeshna, Kirit M., Johnson, Roderick, Verhoef, Gregor, Cunningham, David, de Vos, Sven, Kassam, Shireen, Fayad, Luis, Radford, John, Bailly, Sarah, Offner, Fritz, Morgan, David, Munoz, Javier, Ping, Jerry, Szafer-Glusman, Edith, Eckert, Karl, Neuenburg, Jutta K., Goy, Andre
Publicado 2022

P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH CLL

por Rhodes, Joanna, Shadman, Mazyar, Lamanna, Nicole, S. Manzoor, Beenish, Coombs, Catherine, Ghosh, Nilanjan, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, Alhasani, Hasan, Leslie, Lori, Roeker, Lindsey, Ujjani, Chaitra, Eichhorst, Barbara, Fleury, Isabelle, Skarbnik, Alan, T. Hill, Brian, Lansigan, Frederick, M. Barr, Paul, Davids, Matthew, Fox, Christopher, Choi, Yun, E. Jensen, Christopher, Schuh, Anna, Kennard, Kaitlin, Jawaid, Dureshahwar, Pivneva, Irina, Watson, Talissa, Eyre, Toby
Publicado 2023

P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY

por Lansigan, Frederick, A. Eyre, Toby, Ghosh, Nilanjan, S. Manzoor, Beenish, C. Coombs, Catherine, Lamanna, Nicole, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, E. Roeker, Lindsey, Ujjani, Chaitra, Alhasani, Hasan, Fleury, Isabelle, A. Leslie, Lori, Skarbnik, Alan, Rhodes, Joanna, T. Hill, Brian, M. Barr, Paul, S. Davids, Matthew, P. Fox, Christopher, Choi, Yun, Schuh, Anna, Kennard, Kaitlin, E. Jensen, Christopher, Jawaid, Dureshahwar, Sharma, Aditya, Pivneva, Irina, Watson, Talissa, Shadman, Mazyar
Publicado 2023

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a C...

por Epperla, Narendranath, Ahn, Kwang W., Litovich, Carlos, Ahmed, Sairah, Battiwalla, Minoo, Cohen, Jonathon B., Dahi, Parastoo, Farhadfar, Nosha, Farooq, Umar, Freytes, Cesar O., Ghosh, Nilanjan, Haverkos, Bradley, Herrera, Alex, Hertzberg, Mark, Hildebrandt, Gerhard, Inwards, David, Kharfan-Dabaja, Mohamed A., Khimani, Farhad, Lazarus, Hillard, Lazaryan, Aleksandr, Lekakis, Lazaros, Murthy, Hemant, Nathan, Sunita, Nishihori, Taiga, Pawarode, Attaphol, Prestidge, Tim, Ramakrishnan, Praveen, Rezvani, Andrew R., Romee, Rizwan, Shah, Nirav N., Sureda, Ana, Fenske, Timothy S., Hamadani, Mehdi
Publicado 2019

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma

por Fowler, Nathan H., Samaniego, Felipe, Jurczak, Wojciech, Ghosh, Nilanjan, Derenzini, Enrico, Reeves, James A., Knopińska-Posłuszny, Wanda, Cheah, Chan Y., Phillips, Tycel, Lech-Maranda, Ewa, Cheson, Bruce D., Caimi, Paolo F., Grosicki, Sebastian, Leslie, Lori A., Chavez, Julio C., Fonseca, Gustavo, Babu, Sunil, Hodson, Daniel J., Shao, Spencer H., Burke, John M., Sharman, Jeff P., Law, Jennie Y., Pagel, John M., Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Weiss, Michael S., Zinzani, Pier Luigi
Publicado 2021